Fluciclovine (18F) News
Fluciclovine (18F) currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Fluciclovine (18F) with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: This medicinal product is for diagnostic use only. Axumin is indicated for Positron Emission Tomography (PET) imaging to detect recurrence of prostate cancer in adult men with a suspected recurrence...
- Evidence level: L5
- Predicted indications (20):
- trichotillomania (97.9%)
- Tourette syndrome (97.7%)
- migraine disorder (97.2%)
- migraine with brainstem aura (96.8%)
- erectile dysfunction (disease) (96.3%)
- postural orthostatic tachycardia syndrome (96.1%)
- multifocal atrial tachycardia (disease) (95.6%)
- His bundle tachycardia (95.5%)
- idiopathic neonatal atrial flutter (95.2%)
- hyperthyroidism (94.5%)
- multiple endocrine neoplasia (94.2%)
- atypical coarctation of aorta (93.9%)
- cauda equina syndrome (93.7%)
- hyperthyroxinemia (93.6%)
- resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta (93.5%)
- anaphylaxis (93.2%)
- atrophoderma vermiculata (93.2%)
- thyroid gland disease (93.1%)
- open-angle glaucoma (93.0%)
- ulerythema ophryogenesis (92.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.